Expanded Knowledge about Human Metabolome Expected to Fuel Development of New Therapeutic Drugs and Medical Laboratory Tests

Pathologists and clinical laboratory professionals can expect to see new molecular test development as researchers develop new biomarkers in the wake of expanded knowledge of the genome-metabolome-diseasome correlates One field of science that bears great potential for use in diagnostics and medical laboratory testing involves the human metabolome. Researchers are gaining more understanding of the genetic underpinnings of complex disease and drug response through metabolic pathways. For...

Seven Emerging Life Science Clusters in the United States May Provide Business Opportunities for Clinical Pathology Laboratories

Local medical laboratories and pathology groups can often contract to provide certain services to nearby biotechnology firms Clinical laboratories and pathology groups lucky enough to be located near one of the nation’s recognized “life science clusters” have an opportunity to create useful business relationships with the pharmaceutical firms, biotechnology companies, and medical device businesses that operate within these clusters. Biotech firms located in these life science clusters often...

Rapid Progress in Systems Biology Predicted to Increase Multiplex Testing by Clinical Pathology Laboratories

Trend from reductionism to holistic biomedicine means clinical laboratories and pathologists should expect increased multiplex testing Systems biology (SB) is a rapidly-evolving area of research that, by itself, could greatly expand the need for multiplex testing performed by clinical laboratories. But systems biology has yet to catch the full attention of either the media or Wall Street. That may soon change. Despite the complexity of human metabolic systems, experts in systems biology are...

Decisions in Prometheus, Myriad, and Classen Cases Help Clarify Patent Eligibility Requirements for Genetic Lab Tests and Molecular Diagnostics

Court rulings in several controversial patenting cases are largely consistent Recent decisions from the U.S. Court of Appeals for the Federal Circuit (CAFC) offer some much-needed clarity in the controversial issues surrounding the legality of life sciences patents. This will be of interest to pathologists and medical laboratory managers, because many clinical laboratories and pathology groups must pay royalties to patent-holders for rights to use the technologies. There are multiple legal...

New Innovation Gives Clinical Pathology Laboratories Opportunity to Use Dried Blood Spot Specimens in Medical Lab Testing

More sensitive analytical technologies allow medical laboratories to perform more sophisticated tests using tiny blood specimens on paper New breakthroughs are creating the opportunity to use “dried blood spot” (DBS) technology in an expanded number of pathology and clinical laboratory testing applications. The latest innovation was developed in the United Kingdom and allows more sophisticated applications of this decades-old screening method. This new technology was announced in a press...
;